Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Aims To Boost Transparency Through Earlier Release Of Panel Materials

This article was originally published in The Tan Sheet

Executive Summary

FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a Feb. 28 draft guidance
Advertisement

Related Content

Public Citizen’s Wolfe Joins FDA Advisory Committee
Public Citizen’s Wolfe Joins FDA Advisory Committee
Public Citizen’s Wolfe Joins FDA Advisory Committee
FDA Embraces Controversy Among Reasons To Convene Advisory Committees
FDA Embraces Controversy Among Reasons To Convene Advisory Committees
FDA Extends Conflict Disclosure Policy To All Advisory Panel Members
Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
Advisory Committee Topics Will Narrow In Response To HRG Suit - FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS100272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel